Considerations for Treatment-Free Remission in Patients With Chronic Myeloid Leukemia: A Joint Patient-Physician Perspective

Clinical Lymphoma, Myeloma and Leukemia - United States
doi 10.1016/j.clml.2018.04.005
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Considerations for Successful Treatment-Free Remission in Chronic Myeloid Leukemia

Clinical Lymphoma, Myeloma and Leukemia
Cancer ResearchOncologyHematology
2018English

Telomere Length Shortening Is Associated With Treatment-Free Remission in Chronic Myeloid Leukemia Patients

Journal of Hematology and Oncology
Cancer ResearchOncologyHematologyMolecular Biology
2016English

Leukemia Cutis in a Patient With Chronic Myeloid Leukemia

IOSR Journal of Dental and Medical Sciences
2014English

Treatment-Related Acute Myeloid Leukemia in a Chronic Lymphocytic Leukemia Patient: Role of Fludarabine?

Therapeutic Advances in Hematology
Hematology
2015English

Development of Myasthenia Gravis in a Patient With Chronic Myeloid Leukemia During Treatment With Nilotinib

Hematology Reports
Hematology
2014English

Satisfaction With Information on Nilotinib Treatment in Chronic Myeloid Leukemia Patients

Acta Oncologica
Nuclear MedicineRadiologyHematologyOncologyMedicineImaging
2019English

Therapy - Related Myeloid Neoplasm in a Patient With Prior Treatment for Chronic Lymphocytic Leukemia: A Case Report

Journal of Hematology & Thromboembolic Diseases
2017English

Disease Management and Treatment of Chronic Myeloid Leukemia (CML): Experience From the Patient (Pt) Perspective.

Journal of Clinical Oncology
Cancer ResearchMedicineOncology
2011English

Severe Thrombocytopenia After Dasatinib Treatment in a Patient With Philadelphia Chromosome-Positive Chronic Myeloid Leukemia

OncoTargets and Therapy
OncologyPharmacology
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy